Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2021

May 24, 2021

32163_dirs_2021-05-24_9efc9a68-5bd3-4410-9246-fb54c557aa43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-05-24

Reporting Person: Tupper Colleen (EVP & Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
No securities beneficially owned 0 Direct